Sign in

CIK 0001800315 · Non-accelerated filer<br>Smaller reporting company

Damora Therapeutics, Inc.

Sign in to watch
Ticker
DMRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
371957007
Phone
(781) 281-9020
Business address
100 FIFTH AVENUE, SUITE 700, WALTHAM, MA, 02451
Former names
Galecto, Inc., Galecto Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. ARS Other Annual Report to Security Holders
  4. DEFA14A Proxy Proxy Materials
  5. DEF 14A Proxy Proxy Statement
  6. 10-Q Report Quarterly Report
  7. 4 Open-market sale 10% owner sold 68,481 shares at an average $1.87 ($128,257)
  8. 4 Open-market sale 10% owner sold 67,537 shares at an average $1.80 ($121,357)
  9. 144 Insider Sale of Securities
  10. 144 Insider Sale of Securities
  11. 144 Insider Sale of Securities
  12. 144 Insider Sale of Securities
  13. 4 Open-market sale 10% owner sold 102,630 shares at an average $2.16 ($221,994)
  14. SC 13D/A Stake Beneficial Ownership Report
  15. 144 Insider Sale of Securities
  16. 144 Insider Sale of Securities
  17. 144 Insider Sale of Securities
  18. 144 Insider Sale of Securities
  19. 8-K Event Regulation FD disclosure
  20. S-8 Other Securities Offered to Employees in Benefit Plans

Page 11 of 18 · 353 filings